Bank cites potential ahead of merger. Shares of AbbVie (ABBV) have struggled thanks to fears of increasing regulation in the pharmaceutical sector as well as the company’s announcement to buy competitor Allergan. While the potential merger still faces regulatory approval, Citi Research has upgraded shares of the company to buy from neutral, with a target […]